Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04374734
Other study ID # 7791
Secondary ID
Status Completed
Phase
First received
Last updated
Start date April 5, 2020
Est. completion date June 30, 2020

Study information

Verified date April 2020
Source University Hospital, Strasbourg, France
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Acute respiratory failure (ARF) is a common condition and a common reason for urgent medical consultation. Assessing the extent of respiratory impairment is important to improve the management of patients with ARF. When Acute respiratory failure is caused by pathology of the pulmonary parenchyma, quantification of pulmonary radiographic involvement may be a component of the initial assessment of severity. This radiographic quantification would only be usable in clinical routine if it can be automated and provide a real-time result. The objective of this work is to assess the feasibility of an automated technique for quantifying radiological lung damage in situations of known or potential ARF.


Recruitment information / eligibility

Status Completed
Enrollment 100
Est. completion date June 30, 2020
Est. primary completion date June 30, 2020
Accepts healthy volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients over 18 years of age - Presenting a situation at risk of acute respiratory failure - Requiring thorax imaging when they were treated. Exclusion Criteria: - Patients with anatomically incomplete thoracic imaging (e.g., technical acquisition error).

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
France Service d' Anesthésie Réanimation Chirurgicale Strasbourg

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Strasbourg, France

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Retrospective study of the relationship between severe forms of ARF and the extent of lung involvement 2 months
See also
  Status Clinical Trial Phase
Recruiting NCT04615052 - Home-based Exercise in COVID-19 Survivors N/A
Completed NCT04720794 - A Study To Evaluate The Performance of the Lucira Health All-In-One COVID-19 Test Kit vs Hologic Panther Fusion N/A
Enrolling by invitation NCT04659486 - Adolescents With COVID-19/MIS-C at HCFMUSP N/A
Completed NCT04784481 - Ivermectin Reproposing for Mild Stage COVID-19 Outpatients Phase 1/Phase 2
Recruiting NCT04584658 - Dysphagia and Dysphonia Outcomes in SARS CoV-2 (COVID-19) Infection (DYADS Study)
Active, not recruiting NCT04558476 - Efficacy of CONvalescent Plasma in Patients With COVID-19 Treated With Mechanical Ventilation Phase 2
Withdrawn NCT04456426 - Characteristics of Patients With COVID-19 in Meta State, Colombia
Completed NCT04546581 - Inpatient Treatment of COVID-19 With Anti-Coronavirus Immunoglobulin (ITAC) Phase 3
Completed NCT04446429 - Anti-Androgen Treatment for COVID-19 N/A
Completed NCT04701710 - Prophylaxis Covid-19 in Healthcare Agents by Intensive Treatment With Ivermectin and Iota-carrageenan Phase 1/Phase 2
Enrolling by invitation NCT05054075 - Protocol Design for Evaluating the Immunity of Bivalve Fluids From Anodonta Cygnea in SARS and COVID-19 Phase 2
Withdrawn NCT04590274 - Safety and Efficacy of Hydroxychloroquine for the Treatment & Prevention of Coronavirus Disease 2019 (COVID-19) Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Phase 1
Completed NCT04644159 - Longitudinal Follow-up of a Population Cohort in a French City With High SARS-CoV-2 Circulation, in Early 2020 [COVID-19]
Recruiting NCT04978025 - Colloidal Silver, Treatment of COVID-19 N/A
Enrolling by invitation NCT04540185 - A Phase 3 Randomized Double Blind Efficacy and Safety Study of Oral Polio Vaccine and NA-831 for Covid-19 Phase 3
Recruiting NCT04497454 - Mechanical Ventilation Strategy for Coronavirus Disease 2019 (COVID-19) N/A
Completed NCT04366908 - Prevention and Treatment With Calcifediol of COVID-19 Induced Acute Respiratory Syndrome Phase 2
Active, not recruiting NCT04390412 - Low Dose Radiotherapy in COVID-19 Pneumonia Phase 1/Phase 2
Terminated NCT04382391 - Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms N/A
Recruiting NCT04559113 - Methylprednisolone in COVID-19 Patients (Methyl19LGH) N/A